Cargando…
Cysteine Boosts Fitness Under Hypoxia-Mimicked Conditions in Ovarian Cancer by Metabolic Reprogramming
Among gynecologic malignancies, ovarian cancer is the third most prevalent and the most common cause of death, especially due to diagnosis at an advanced stage together with resistance to therapy. As a solid tumor grows, cancer cells in the microenvironment are exposed to regions of hypoxia, a selec...
Autores principales: | Nunes, Sofia C., Ramos, Cristiano, Santos, Inês, Mendes, Cindy, Silva, Fernanda, Vicente, João B., Pereira, Sofia A., Félix, Ana, Gonçalves, Luís G., Serpa, Jacinta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386479/ https://www.ncbi.nlm.nih.gov/pubmed/34458274 http://dx.doi.org/10.3389/fcell.2021.722412 |
Ejemplares similares
-
Cysteine boosters the evolutionary adaptation to CoCl(2) mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer
por: Nunes, Sofia C., et al.
Publicado: (2018) -
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
por: Nunes, Sofia C., et al.
Publicado: (2018) -
Hypoxia in Cell Reprogramming and the Epigenetic Regulations
por: Nakamura, Nariaki, et al.
Publicado: (2021) -
Cysteine Aminotransferase (CAT): A Pivotal Sponsor in Metabolic Remodeling and an Ally of 3-Mercaptopyruvate Sulfurtransferase (MST) in Cancer
por: Hipólito, Ana, et al.
Publicado: (2020) -
Cysteine metabolic circuitries: druggable targets in cancer
por: Bonifácio, Vasco D. B., et al.
Publicado: (2020)